Prospective biomarker trials chemo N0 and NNBC-3 Europe validate the clinical utility of invasion markers uPA and PAI-1 in node-negative breast cancer.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Works matching IS 16613791 AND DT 2008 AND VI 3 AND IP S2
Results: 6
1
2
Assessment of urokinase-type plasminogen activator and its inhibitor PAI-1 in breast cancer tissue: historical aspects and future prospects.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
3
uPAR and HER2 genes are usually co-amplified in individual breast cancer cells from blood and tissues.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
4
The role of uPA and uPA inhibitors in breast cancer.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
5
The oral serine protease inhibitor WX-671 - first experience in patients with advanced head and neck carcinoma.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
6
Experience in phase I trials and an upcoming phase II study with uPA inhibitors in metastatic breast cancer.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article